These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11529255

  • 1. Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy.
    McCormack JG, Westergaard N, Kristiansen M, Brand CL, Lau J.
    Curr Pharm Des; 2001 Sep; 7(14):1451-74. PubMed ID: 11529255
    [Abstract] [Full Text] [Related]

  • 2. Intervention of hepatic glucose production. Small molecule regulators of potential targets for Type 2 diabetes therapy.
    Barf T.
    Mini Rev Med Chem; 2004 Oct; 4(8):897-908. PubMed ID: 15544551
    [Abstract] [Full Text] [Related]

  • 3. New hepatic targets for glycaemic control in diabetes.
    Agius L.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):587-605. PubMed ID: 18054737
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological regulation of hepatic glucose production.
    Link JT.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):421-9. PubMed ID: 12808881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glycogen phosphorylase inhibitors.
    Henke BR, Sparks SM.
    Mini Rev Med Chem; 2006 Aug; 6(8):845-57. PubMed ID: 16918491
    [Abstract] [Full Text] [Related]

  • 11. Current anti-diabetic agents and their molecular targets: A review.
    Kerru N, Singh-Pillay A, Awolade P, Singh P.
    Eur J Med Chem; 2018 May 25; 152():436-488. PubMed ID: 29751237
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of increased glucose production: identifying potential therapeutic targets.
    Proietto J, Andrikopoulos S.
    J Investig Med; 2004 Sep 25; 52(6):389-93. PubMed ID: 15612452
    [Abstract] [Full Text] [Related]

  • 13. Interdependence of hepatic lipid and glucose metabolism: novel pharmacological targets for diabetes.
    Lind P.
    Curr Opin Investig Drugs; 2004 Apr 25; 5(4):395-401. PubMed ID: 15134280
    [Abstract] [Full Text] [Related]

  • 14. New insights into the anti-diabetic actions of metformin: from the liver to the gut.
    Wu T, Horowitz M, Rayner CK.
    Expert Rev Gastroenterol Hepatol; 2017 Feb 25; 11(2):157-166. PubMed ID: 27983877
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.
    Rines AK, Sharabi K, Tavares CD, Puigserver P.
    Nat Rev Drug Discov; 2016 Nov 25; 15(11):786-804. PubMed ID: 27516169
    [Abstract] [Full Text] [Related]

  • 17. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.
    Li YG, Ji DF, Zhong S, Lin TB, Lv ZQ.
    Chem Biol Interact; 2015 Jan 05; 225():70-9. PubMed ID: 25446853
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of glucagon secretion.
    Young A.
    Adv Pharmacol; 2005 Jan 05; 52():151-71. PubMed ID: 16492545
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.